You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRCA germ-line mutation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer With or Without BRCA Mutation

Recruiting
  • Breast Cancer
  • Androgen receptor status and BRCA mutation
  • Varanasi, UP, India
    Banaras Hindu University
Jun 2, 2022

Pancreatic Ductal Adenocarcinoma Trial in Milan (Chlorambucil, Oral, 2 Mg)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Chlorambucil, Oral, 2 Mg
  • Milan, Italy
    IRCCS San Raffaele
Dec 30, 2020

Metastatic Castration Resistant Prostate Cancer Trial (S410914 tablet)

Unknown status
  • Metastatic Castration Resistant Prostate Cancer
  • S410914 tablet
  • (no location specified)
Jul 24, 2020

Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

Enrolling by invitation
  • Breast Cancer
  • +7 more
  • Dnipro, Ukraine
  • +1 more
Jun 17, 2023

Ovarian Epithelial Cancer, Carcinoma in Situ, Ovarian Cancer Trial in Worldwide (Lavage of the Cavum uteri and proximal

Completed
  • Ovarian Epithelial Cancer
  • +2 more
  • Lavage of the Cavum uteri and proximal Fallopian tubes, performed in the luteal phase of the female cycle
  • Graz, Austria
  • +13 more
Sep 1, 2022

Breast Cancer Trial in Los Angeles (Pembrolizumab, Olaparib)

Active, not recruiting
  • Breast Cancer
  • Los Angeles, California
    Cedars-Sinai Medical Center
Feb 1, 2023

Breast & Ovarian Cancer Risk Detection

Recruiting
  • Adnexal Mass
  • +3 more
  • OVA360
  • Austin, Texas
    Silvana Franco
Jul 20, 2022

Ovarian Tumors Trial in Rome (Trabectedin, Pegylated Liposomal Doxorubicin, Topotecan)

Completed
  • Ovarian Neoplasms
  • Rome, Italy
    Domenica Lorusso
Aug 24, 2021

Ovarian Cancer Trial in Worldwide (Alpelisib, Olaparib, Paclitaxel)

Recruiting
  • Ovarian Cancer
  • Phoenix, Arizona
  • +116 more
Nov 25, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Guangzhou (Pamiparib)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Apr 7, 2022

Pancreatic Tumors Trial in Shanghai (Sofantinib?abraxane?gemcitabine, Abraxane combined with gemcitabine)

Not yet recruiting
  • Pancreatic Neoplasms
  • Shanghai, China
    Fudan University ShangHai Cancer Center
Jul 31, 2023

Metastatic BRCA-Associated Breast Carcinoma, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in

Active, not recruiting
  • Metastatic BRCA-Associated Breast Carcinoma
  • +5 more
  • Anchorage, Alaska
  • +815 more
Aug 5, 2022

Ovarian Tumor Epithelial, Homologous Recombination Deficiency, BRCA1 Mutation Trial in Groningen, Leiden, Rotterdam (Functional

Recruiting
  • Ovarian Neoplasm Epithelial
  • +3 more
  • Functional RAD51 assay
  • Olaparib Oral Product
  • Groningen, Netherlands
  • +2 more
Mar 30, 2021

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +44 more
  • Biopsy
  • +23 more
  • Birmingham, Alabama
  • +166 more
Feb 2, 2023

Pancreatic Ductal Adenocarcinoma Trial in Israel, United States (The risk assessment questionnaire, Blood specimens, tumor

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • The risk assessment questionnaire
  • +2 more
  • Basking Ridge, New Jersey
  • +12 more
Dec 22, 2022

Metastatic Breast Cancer Trial in Lyon, Marseille (rucaparib)

Completed
  • Metastatic Breast Cancer
  • Lyon, France
  • +1 more
Jun 5, 2021

Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity Trial in Canada, United States (OLAPARIB)

Completed
Has Results
  • Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity
  • Anchorage, Alaska
  • +46 more
Mar 22, 2022

Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or

Recruiting
  • Ovarian Cancer
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Jul 13, 2022

    Breast Cancer, Genetic Predisposition Trial in Rome, Varese (Genetic predisposition to breast cancer)

    Recruiting
    • Breast Cancer
    • Genetic Predisposition
    • Genetic predisposition to breast cancer
    • Rome, Italy
    • +1 more
    May 4, 2023

    Cancer of the Pancreas Screening Study (CAPS 3)

    Completed
    • Pancreatic Neoplasm
    • Peutz-Jeghers Syndrome
    • Biopsy, Fine Needle Aspiration (FNA)
    • Secretin (human synthetic) - ChiRhoClin
    • Baltimore, Maryland
      Johns Hopkins Hospital
    Jun 17, 2021

    Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, High Grade Endometrioid Ovarian Cancer Trial in Guangzhou (Fluzoparib

    Not yet recruiting
    • Ovarian Cancer
    • +4 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Cetntre
    Sep 25, 2023

    Pediatric Germ Cell Tumor Trial in Seoul (TIP treatment (paclitaxel/ifosfamide/cisplatin))

    Recruiting
    • Pediatric Germ Cell Tumor
    • TIP treatment (paclitaxel/ifosfamide/cisplatin)
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Jul 8, 2022

    Collect Real-world Clinical and Patient-reported Outcomes in

    Recruiting
    • Ovarian Cancer
      • Aachen, Germany
      • +64 more
      Jul 29, 2022

      Ovarian Cancer, Breast Cancer Trial in India (Olaparib)

      Completed
      • Ovarian Cancer
      • Breast Cancer
      • Ahmedabad, India
      • +15 more
      Oct 28, 2022

      Cancer Trial in Los Angeles (KRAS-variant and microRNA binding site mutation testing)

      Recruiting
      • Cancer
      • KRAS-variant and microRNA binding site mutation testing
      • Los Angeles, California
        MiraKind
      Aug 24, 2021